It’s been a battle to get drug manufacturers to make medicines needed by people in developing countries, drugs to treat diseases expunged from wealthy nations. But what happens when the drugs finally reach these populations – do they work? Are they being used safely? Are there nasty side effects?
Becky Bartlein is trying to answer these questions as part of the newly formed Global Medicines Program at the University of Washington.
